Talk:Adrenocorticotropic hormone

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Mid-importance).

Untitled[edit]

Same as with Corticotropin-releasing hormone, "corticotrophin" is probably misspelt, explanation see there. Kosebamse 17:03, 4 Nov 2003 (UTC)

In accordance with Wikipedia:WikiProject_Drugs naming policy, I propose we move this page to the INN corticotropin. If you have any concern with this proposal, please discuss it on this page. Matt 00:01, 22 Dec 2004 (UTC)

Is POMC 241 amino acids or 267? —Preceding unsigned comment added by 194.72.81.141 (talk) 17:02, 24 May 2009 (UTC)[reply]

Wiki Education Foundation-supported course assignment[edit]

This article was the subject of a Wiki Education Foundation-supported course assignment, between 9 January 2020 and 24 April 2020. Further details are available on the course page. Peer reviewers: Magdala5.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 13:27, 16 January 2022 (UTC)[reply]

New FDA approvals for Acthar® Gel?[edit]

This seems to be a new development on this topic.

http://www.digitaljournal.com/pr/754712

http://www.marketwatch.com/story/questcor-announces-conference-call-and-webcast-on-june-14-2012-to-review-commercialization-strategy-for-rheumatology-indications-for-acthar-2012-06-11

"to review the Company's commercialization strategy for H.P. Acthar® Gel (repository corticotropin injection) for the following rheumatology-related FDA-approved indications on the label for Acthar:

Collagen Diseases: "during an exacerbation or as maintenance therapy in selected cases of: systemic lupus erythematosus, systemic dermatomyositis (polymyositis)."

Rheumatic Disorders: "as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: Psoriatic arthritis, Rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy), Ankylosing spondylitis." " 50.71.203.92 (talk) 15:41, 1 July 2012 (UTC)[reply]

POMC?[edit]

I don't get it, why there is a POMC in infobox, when the article is about ACTH?? --Petr Flosman (talk) 21:48, 27 January 2013 (UTC)[reply]

A: ACTH is derived from the POMC peptide. — Preceding unsigned comment added by InsaneInnerMembrane (talk • contribs) 11:03, 3 June 2015 (UTC)[reply]

"ATCH" listed at Redirects for discussion[edit]

An editor has asked for a discussion to address the redirect ATCH. Please participate in the redirect discussion if you wish to do so. œ^™ 06:22, 3 November 2019 (UTC)[reply]